Immodulators, Volume 151 explores the pivotal role immodulators play in regulating immune responses for health and disease management. The book provides an in-depth overview of various classes of immunomodulatory agents, including biologics, small molecules, natural compounds, and synthetic drugs, examining their mechanisms of action and therapeutic applications. Chapters in this new release include Marine-Derived Polysaccharides and Peptides as Next-Generation Immunomodulators: Molecular Mechanisms, Therapeutic Potential, and Translational Challenges, Advances in Immunomodulation: From Dietary Influence to Computational Precision, iPSC-derived immunotherapy for Tau and Alzheimer's disease, and much more.
Additional sections cover Antibodies targeting amyloid-β and Tau oligomers in Alzheimer's Disease, Biosimilars: Antibody and Nanobody Based Therapeutic Approaches Towards Protein Misfolding Diseases, Immunomodulator drugs: mechanisms of action and systemic effects, Microbiome and microbial products as immunomodulators: implication for gastrointestinal cancers, Integration of Network pharmacology, docking, and dynamics analysis to investigate the immunomodulatory activity of Pongamia pinnata, Transcriptomic Insights into Epigenetic and Immunomodulatory Roles of Nuclear Histone Genes in Bladder Cancer: A bioinformatics Approach, Utilizing DREIMT Database for Drug Prioritization in Immunomodulatory Therapy for Psoriasis and Psoriatic Arthritis, and many additional topics.
1. Title of Book - p. i 2. Cover image - p. i 3. Title page - p. ii 4. Table of Contents - p. iii 5. Copyright - p. iv 6. Contributors - p. xiii 7. Chapter One: Immunomodulator drugs: Mechanism of action and systemic effects - p. 1 8. Chapter Two: Advances in immunomodulation: From dietary influence to computational precision - p. 29 9. Chapter Three: Marine-derived polysaccharides and peptides as next-generation immunomodulators: Molecular mechanisms, therapeutic potential, and translational challenges - p. 45 10. Chapter Four: Synthetic immunomodulators: Revolutionizing immunotherapy - p. 101 11. Chapter Five: Biosimilars: Antibody and nanobody-based therapeutic approaches towards protein misfolding diseases - p. 157 12. Chapter Six: Induced-pluripotent stem cell-derived immunotherapy for Tau and Alzheimer’s disease - p. 197 13. Chapter Seven: Antibodies targeting amyloid-β and Tau oligomers in Alzheimer’s disease - p. 225 14. Chapter Eight: Therapeutics immunotargets for Tauopathy - p. 267 15. Chapter NIne: Antioxidants as immunomodulators for Tau and Amyloid-β in Alzheimer’s disease - p. 303
Immodulators, Volume 151 explores the pivotal role immodulators play in regulating immune responses for health and disease management. The book provides an in-depth overview of various classes of immunomodulatory agents, including biologics, small molecules, natural compounds, and synthetic drugs, examining their mechanisms of action and therapeutic applications. Chapters in this new release include Marine-Derived Polysaccharides and Peptides as Next-Generation Immunomodulators: Molecular Mechanisms, Therapeutic Potential, and Translational Challenges, Advances in Immunomodulation: From Dietary Influence to Computational Precision, iPSC-derived immunotherapy for Tau and Alzheimer's disease, and much more.
Additional sections cover Antibodies targeting amyloid-β and Tau oligomers in Alzheimer's Disease, Biosimilars: Antibody and Nanobody Based Therapeutic Approaches Towards Protein Misfolding Diseases, Immunomodulator drugs: mechanisms of action and systemic effects, Microbiome and microbial products as immunomodulators: implication for gastrointestinal cancers, Integration of Network pharmacology, docking, and dynamics analysis to investigate the immunomodulatory activity of Pongamia pinnata, Transcriptomic Insights into Epigenetic and Immunomodulatory Roles of Nuclear Histone Genes in Bladder Cancer: A bioinformatics Approach, Utilizing DREIMT Database for Drug Prioritization in Immunomodulatory Therapy for Psoriasis and Psoriatic Arthritis, and many additional topics.
1. Title of Book - p. i 2. Cover image - p. i 3. Title page - p. ii 4. Table of Contents - p. iii 5. Copyright - p. iv 6. Contributors - p. xiii 7. Chapter One: Immunomodulator drugs: Mechanism of action and systemic effects - p. 1 8. Chapter Two: Advances in immunomodulation: From dietary influence to computational precision - p. 29 9. Chapter Three: Marine-derived polysaccharides and peptides as next-generation immunomodulators: Molecular mechanisms, therapeutic potential, and translational challenges - p. 45 10. Chapter Four: Synthetic immunomodulators: Revolutionizing immunotherapy - p. 101 11. Chapter Five: Biosimilars: Antibody and nanobody-based therapeutic approaches towards protein misfolding diseases - p. 157 12. Chapter Six: Induced-pluripotent stem cell-derived immunotherapy for Tau and Alzheimer’s disease - p. 197 13. Chapter Seven: Antibodies targeting amyloid-β and Tau oligomers in Alzheimer’s disease - p. 225 14. Chapter Eight: Therapeutics immunotargets for Tauopathy - p. 267 15. Chapter NIne: Antioxidants as immunomodulators for Tau and Amyloid-β in Alzheimer’s disease - p. 303
